HDL and Oxidation.

Area of Science:

• Biochemistry
• Cardiovascular Research
• Oxidative Stress Biology

Background:

• High-density lipoproteins (HDLs) possess antioxidant properties crucial for preventing atherosclerosis.
• Apolipoprotein A-I (ApoA-I) is identified as the principal antioxidant component within HDLs.
• Oxidation of low-density lipoproteins (LDL) and other oxidants are key contributors to cardiovascular disease pathogenesis.

Purpose of the Study:

• To elucidate the mechanisms by which HDLs inhibit LDL oxidation and neutralize oxidants.
• To explore the role of HDL's antioxidant capacity in regulating inflammation and cholesterol transport.
• To evaluate HDL oxidation as a potential therapeutic target for various diseases, including atherosclerosis and metabolic disorders.

Main Methods:

• Analysis of apolipoprotein A-I (ApoA-I) regulation within HDLs.
• Investigation of HDL lipidome alterations and proteomic modifications (e.g., MPO, PON1).
• Assessment of the impact of HDL oxidation on inflammatory pathways and cholesterol transport processes.

Main Results:

• HDL's antioxidant capacity is significantly influenced by ApoA-I levels and modifications.
• Alterations in HDL's lipidome and proteome, particularly MPO and PON1, modulate its antioxidant function.
• HDL oxidation is intrinsically linked to inflammatory processes and cholesterol transport dynamics.

Conclusions:

• The antioxidant activity of HDLs is a critical factor in mitigating oxidative stress relevant to cardiovascular health.
• Modulating HDL's antioxidant properties through ApoA-I regulation and proteomic/lipidomic adjustments presents a viable therapeutic avenue.
• Targeting HDL oxidation holds significant potential for treating atherosclerosis, metabolic diseases, and other oxidant-related pathologies.